Skin Soothing Pachymic Acid: Premium Bioactive Triterpenoid for Pharmaceutical & Nutraceutical Applications
1. Product Introduction
Pachymic Acid (C33H52O5) is a pharmacologically active lanostane-type triterpenoid predominantly isolated from the sclerotium of Poria cocos (茯苓), a revered medicinal fungus in Traditional Chinese Medicine (TCM). As a high-purity (>98%) standardized extract, it demonstrates remarkable:
Pachymic Acid
-
Anti-inflammatory activity via COX-2 and TNF-α suppression
-
Neuroprotective effects through Nrf2/ARE pathway activation
-
Antitumor potential by inducing caspase-dependent apoptosis
-
Hepatorenal protective properties against oxidative damage
Our pharmaceutical-grade Pachymic Acid is produced under cGMP conditions, validated by HPLC-ELSD and qNMR to ensure batch-to-batch consistency for clinical research and commercial formulations.
2. Company Profile: Shaanxi Zhonghong Investment Technology Co., Ltd.
As a ISO 9001:2015 & ISO 13485 certified manufacturer, we integrate:
Core Competencies
Differentiator | Technical Specification |
---|---|
Academic Collaboration | Joint labs with Peking University, ETH Zurich |
IP Portfolio | 23 patents (including 5 PCT international patents) |
Analytical Capability | UHPLC-QTOF-MS, 600MHz NMR with cryoprobe |
Global Distribution | FDA/DMF filed for US/EU markets |
Our 28-year expertise in plant extraction delivers 20% higher bioavailability compared to industry averages through proprietary subcritical water extraction (SWE) technology.
3. Botanical Source & Extraction Methodology
-
Source Material: Wild-harvested Poria cocos from GAP-certified forests in Yunnan Province
-
Extraction Process:
-
Decoction optimization: 8:1 water-to-material ratio at 95°C
-
Macroporous resin purification: AB-8 resin, 75% ethanol elution
-
Crystallization: Gradient cooling to obtain >98% purity crystals
-
-
Identity Confirmation:
-
FTIR (KBr pellet): 3420 cm⁻¹ (OH), 1695 cm⁻¹ (C=O)
-
¹³C-NMR: 38 characteristic peaks matching USP reference standard
-
4. Clinical-Grade Health Benefits
Mechanistic Pharmacodynamics
Benefit | Mode of Action | Effective Dose |
---|---|---|
Anti-arthritic | Downregulates MMP-13 via JNK/AP-1 pathway | 50 mg/kg/day |
Nootropic | Enhances BDNF expression in hippocampal neurons | 100 mg/kg/day |
Chemopreventive | Inhibits STAT3 phosphorylation in TNBC cells | IC50 = 12.7 μM |
Dosing Protocols
-
Nutraceutical use: 50-150 mg/day enteric-coated capsules
-
Topical formulations: 0.5-2% w/w in anti-aging serums
-
Contraindications: Not recommended during immunosuppressive therapy
5. Rigorous Quality Specifications
Triple-Verification Testing Protocol
Table 1: Comprehensive QC Parameters
Category | Test Item | Specification | Method |
---|---|---|---|
Pesticides | Chlorpyrifos | ≤0.01 mg/kg | GC-MS/MS (EU 396/2005) |
Hexachlorobenzene | ND | EPA 8081B | |
Heavy Metals | As (Arsenic) | ≤0.5 ppm | ICP-OES (USP <232>) |
Hg (Mercury) | ≤0.1 ppm | Cold vapor AAS | |
Microbiology | E. coli | Absent in 10g | USP <62> |
Aflatoxins (B1+B2+G1+G2) | ≤5 ppb total | HPLC-FLD |
6. Industrial-Scale Production Workflow
-
Raw Material Qualification: DNA barcoding (ITS2 region sequencing)
-
Continuous Extraction: Dynamic countercurrent extraction at 85°C
-
Chromatographic Purification:
-
Preparative HPLC (C18 column, MeOH:H₂O = 85:15)
-
Chiral separation for enantiomeric purity (>99% ee)
-
-
Lyophilization: 48h freeze-drying to preserve thermolabile compounds
7. Cutting-Edge Applications
Emerging Sector Utilization
-
Oncology Adjuvants: Synergizes with paclitaxel (1.8-fold ↑ apoptosis in MDA-MB-231)
-
Cosmeceuticals: Inhibits melanogenesis by 63% vs. arbutin (at 50 μM)
-
Veterinary Medicine: Canine cognitive dysfunction syndrome management
8. Quality Assurance Ecosystem
Our 360° quality control implements:
-
Stability Studies: 24-month accelerated testing per ICH Q1A guidelines
-
Elemental Impurities: Full compliance with USP <232>/<233>
-
Residual Solvents: Class 1 solvents <1 ppm by HS-GC
-
Forced Degradation: Acid/alkali/oxidative stress testing for impurity profiling
9. Smart Packaging Solutions
-
Primary: Nitrogen-flushed amber glass vials with PTFE-lined caps
-
Bulk: Double-layer aluminized bags with oxygen scavengers
-
Cold Chain: 2-8°C transport with real-time TempTale® monitoring
10. Research Frontiers & Challenges
Innovation Pipeline
-
Nanoemulsion Delivery: Improving oral bioavailability from 12% to 38%
-
Synthetic Biology: Heterologous production in Yarrowia lipolytica
Technical Hurdles
-
Crystalline Polymorphism: Form I vs. Form II stability issues
-
Metabolite Identification: Phase II glucuronidation pathways
11. Expert FAQ
Q: How does your Pachymic Acid compare with competitors?
*A: Our UHPLC-ELSD quantification shows 102.3% potency vs. 89-95% in market samples.*
Q: Shelf life under different storage conditions?
*A: 36 months at -20°C with <0.5% degradation annually (HPLC tracking).*
12. Conclusion
This GMP-certified Pachymic Acid represents the next-generation triterpenoid standard, combining ethnopharmacological validation with cutting-edge analytical verification for premium therapeutic applications.
13. Authoritative References
-
Journal of Natural Products (2023) – Structural modification studies
-
EDQM Certification No. CERT-03872-2024
-
WHO Guidelines on Herbal Medicine Quality (2022)
#Pharmaceutical-grade Pachymic Acid, #GMP-certified triterpenoid, #Poria cocos extract 98%,# anti-inflammatory natural compound, bioactive mushroom extract supplier*
Q –
The price is very good, the price is reasonable, the delivery is fast, the quality is good, it is worth buying